Clinical Trial Update: A Phase 2 Extension Study of Study GCS-100-CS-4002 [Phase 2]

View source ↗

Summary

This document notes the completion of a Phase 2 extension study for the investigational drug GCS-100-CS-4002 in chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• GCS-100-CS-4002

Snippet

Sponsor: La Jolla Pharmaceutical Company | Conditions: Chronic Kidney Disease | Phase 2 | Status: COMPLETED